Searchable abstracts of presentations at key conferences in endocrinology

ea0014p531 | (1) | ECE2007

Long-term evaluation of hypotalamic-pituitary-adrenal (HPA) axis in acromegalic patients during somatostatin analogs therapy and after successful surgery

Ronchi Cristina L , Rizzo Erica , Ferrante Emanuele , Giavoli Claudia , Lania Andrea G , Beck-Peccoz Paolo , Spada Anna

Long-term effects of trans-naso-sphenoidal surgery (TNS) and long-acting somatostatin analogs (SSTa) on hypotalamic-pituitary-adrenal (HPA) function have been poorly investigated. Aim of the study was to evaluate over time the integrity of HPA axis in acromegalic patients with baseline preserved adrenal function and treated with one or both available treatments. We selected 23 patients (15F & 8M, age (±S.D.)=46.8±13.7 yrs) with normal (n=19)...

ea0056oc5.3 | Diving deep into adrenal cortex diseases | ECE2018

PRKACA L206R mutation in adrenal Cushing’s syndrome makes PKA RIIβ susceptible for caspase-mediated cleavage

Weigand Isabel , Ronchi Cristina L. , Hofner Kerstin , Vanselow Jens T. , Herterich Sabine , Bathon Kerstin , Schlosser Andreas , Fassnacht Martin , Calebiro Davide

Protein Kinase A (PKA) consists of two catalytic and two regulatory subunits with several isoforms (Cα, β, γ and RIα, IIα, Iβ, IIβ, respectively). Type II regulatory subunits are phosphorylated by PKA in their inhibitory sites, while type I are not. Somatic activating mutations in the gene encoding the catalytic subunit α (Cα) of PKA (PRKACA) have been found in 30–40% of cortisol-producing adrenocortical adenomas (CPA). We rece...

ea0056gp32 | Adrenal cortex | ECE2018

PRKACA L206R mutation in adrenal Cushing induces histone H1.4 hyper-phosphorylation

Bathon Kerstin , Weigand Isabel , Vanselow Jens T , Ronchi Cristina L , Sbiera Silviu , Schlosser Andreas , Fassnacht Martin , Calebiro Davide

We previously identified mutations in PRKACA, coding for the catalytic a (Ca) subunit of protein kinase A (PKA), as the main genetic alteration in cortisol-producing adrenal adenomas (CPAs) responsible for Cushing’s syndrome. Here, we further investigated the mechanism of action of all PRKACA mutations identified so far by our team (L206R, L199_C200_insW, S213R_L212_K214insIILR, C200_GlyinsV, W197R, del244-248+E249Q and E32V). Five out of seven mutants s...

ea0049gp1 | Adrenal 1 | ECE2017

PRKACA mutations in adrenal Cushing can alter substrate specificity

Bathon Kerstin , Weigand Isabel , Vanselow Jens T , Ronchi Cristina L , Di Dalmazi Guido , Beuschlein Felix , Sbiera Silviu , Schlosser Andreas , Fassnacht Martin , Calebiro Davide

Previously, we identified seven mutations in the main catalytic subunit of protein kinase A (PKA Cα) to be responsible for cortisol-secreting adrenocortical adenomas (CPAs): L206R, L199_C200_insW, S213R_L212_K214insIILR, C200_GlyinsV, W197R, del244-248+E249Q, E32V. Here we performed a functional characterization of these mutants. Specifically, we evaluated the association between PKA regulatory and catalytic subunits using co-immunoprecipitation and PKA activity using a k...

ea0049gp119 | Endocrine Tumours | ECE2017

Targeted molecular analysis in adrenocortical carcinomas: a way towards personalized medicine

Ronchi Cristina L , Lippert Juliane , Appenzeller Silke , Sbiera Silviu , Steinhauer Sonja , Liang Raimunde , Gehrig Andrea , Kroiss Matthias , Rost Simone , Rosenwald Andreas , Muller-Reible Clemens , Fassnacht Martin

Adrenocortical carcinoma (ACC) is a rare tumor with heterogeneous outcome and no available targeted therapy. The aim of the study is to identify prognostic molecular markers and novel potential drug targets.A total of 43 FFPE tumor samples were retrospectively investigated for somatic mutations and copy number variations (CNV) by next-generation sequencing (160 cancer-related genes, Qiagen). Gene expression was evaluated by quantitative RT-PCR in a subgr...

ea0049ep20 | Adrenal cortex (to include Cushing's) | ECE2017

Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells

Catalano Rosa , Peverelli Erika , Giardino Elena , Treppiedi Donatella , Morelli Valentina , Chiodini Iacopo , Marcon Lorenzo , Ronchi Cristina L , Bertherat Jerome , Beuschlein Felix , Arosio Maura , Spada Anna , Mantovani. Giovanna

The cAMP signaling pathway plays a major role in the pathogenesis of cortisol-producing adrenocortical adenomas (CPA). In adrenocortical cells cAMP induces dramatic changes in cell morphology accompanied by actin cytoskeleton rearrangements that precede steroidogenesis, the causal relationship between these events being still undefined. In this study we investigated cAMP effects on cytoskeleton rearrangements and steroidogenic response in mouse (Y1) and human adrenocortical tu...

ea0049ep161 | Endocrine tumours and neoplasia | ECE2017

CYP2W1*6 polymorphism as a potential predictive marker of sensitivity to mitotane treatment in adrenocortical carcinoma.

Altieri Barbara , Herterich Sabine , Sbiera Silviu , Volante Marco , Kroiss Matthias , Casa Silvia Della , Pontecorvi Alfredo , Terzolo Massimo , Fassnacht Martin , Ronchi Cristina L.

Mitotane is the only approved drug for the treatment of advanced adrenocortical carcinoma (ACC) and we recently demonstrated that a high expression of cytochrome P450 2W1 (CYP2W1) correlated with response to mitotane. The association between CYP2W1 alleles and a generally increased cancer risk is under debate. Aim of the study was to evaluate the frequency of CYP2W1 polymorphisms and its correlation with the response to mitotane treatment in ACC patients.<p class="abstext"...

ea0037ep1131 | Endocrine tumours | ECE2015

Inhibitor of apoptosis protein livin/BIRC7 in adrenocortical tumours

Altieri Barbara , Sbiera Silviu , Casa Silvia Della , Steinhauer Sonja , Wild Vanessa , Fadda Guido , Bekteshi Michaela , Rosenwald Andreas , Pontecorvi Alfredo , Fassnacht Martin , Allolio Bruno , Ronchi Cristina L

Introduction: Adrenocortical tumours comprise frequent adenomas (ACA) and rare highly malignant carcinoma (ACC). Livin/ML-IAP/BIRC7 is a member of the inhibitors of apoptosis proteins family, which are involved in tumorigenesis, mostly through the inhibition of caspase-3. Aim of the study was to evaluate the expression of livin/BIRC7 in normal and neoplastic adrenal glands.Methods: The mRNA expression of BIRC7, its isoforms livin α...

ea0035oc5.3 | Adrenal &amp; Thyroid | ECE2014

Mitotane induces endoplasmic reticulum stress triggering apoptosis and decrease of steroid hormone synthesis

Sbiera Silviu , Wiemer Laura , Leich Ellen , Gehl Annemarie , Gardill Felix , Ronchi Cristina L. , Bala Margarita , Schirbel Andreas , Rosenwald Andreas , Allolio Bruno , Fassnacht Martin , Kroisz Matthias

Background: Mitotane is the only drug approved for treatment of adrenocortical carcinoma (ACC). Molecular events leading to cell death in adrenocortical cells are unknown preventing the development of drugs with improved efficacy-toxicity ratio.Methods: We employed the ACC model cell line NCI-H295 to investigate the effects of mitotane on genome-wide mRNA expression using microarray analysis. Several algorithms were used to delineate signaling pathways t...

ea0014p592 | (1) | ECE2007

Evaluation of hypotalamic-pituitary-gonadal (HPG) axis and GH-IGF-I axis in adult patients with celiac disease

Ferrante Emanuele , Giavoli Claudia , Bergamaschi Silvia , Elli Luca , De Bellis Annamaria , Ronchi Cristina L , Lania Andrea , Teresa Bardella Maria , Bellastella Antonio , Beck-Peccoz Paolo , Spada Anna

Celiac disease is a chronic inflammatory autoimmune disorder often associated with other endocrine autoimmune diseases, such as type I diabetes mellitus, Addison’s disease and Hashimoto’s thyroiditis. In these patients, LH, FSH and GH secretion has been poorly investigated. Aim of this study is to evaluate anterior pituitary function, and in particular hypotalamic-pituitary-gonadal (HPG) axis and GH-IGF-I axis, in adult patients with treated celiac disease. For this ...